Literature DB >> 30196469

Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features.

Anna Bläckberg1, Bo Nilson2,3, Volkan Özenci4,5, Lars Olaison6,7, Magnus Rasmussen8.   

Abstract

Knowledge of infective endocarditis (IE) caused by Streptococcus dysgalactiae (SD) is limited. This study aimed to identify the clinical and microbiological features of SD-caused IE and to investigate any possible synergy between penicillin and gentamicin on SD isolates. Cases of IE 2008-2016 due to SD reported to the Swedish Registry of Infective Endocarditis (SRIE) were identified. Isolates were emm typed and synergy between antibiotics was determined in time-kill experiments. Medical records were reviewed and SD-cases were compared to cases of IE due to other pathogens reported to the SRIE. Fifty cases of SD-caused IE were confirmed. emm types stC74a, stG62647, and stG643 were most commonly encountered. The patients had a median age of 74 years (range 38-93) and were significantly older compared to patients with Staphylococcus aureus-caused IE, (65 years (p = 0.003)). The median time to diagnosis from symptom onset was 1 day for patients with SD-caused IE which was less compared to patients with IE due to the other pathogens (2-15 days). Embolization was seen in 46% and the in-hospital mortality was 8%. Etest-based methods did not indicate any synergy between penicillin and gentamicin whereas synergy was noted for four out of nine isolates applying time-kill assays. This is the largest study of SD-caused IE, a condition with an acute onset predominantly affecting elderly people. Synergy between penicillin and gentamicin against some SD isolates was distinguished but the potential benefit of this must be weighed against the risk of aminoglycoside side effects.

Entities:  

Keywords:  Antibiotic susceptibility; Infective endocarditis; Streptococcus dysgalactiae; emm type

Mesh:

Substances:

Year:  2018        PMID: 30196469     DOI: 10.1007/s10096-018-3367-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes.

Authors:  Anders Jensen; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 3.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

4.  Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen.

Authors:  Daisuke Tanaka; Junko Isobe; Masanori Watahiki; Yoshiyuki Nagai; Chihiro Katsukawa; Ryuji Kawahara; Miyoko Endoh; Rumi Okuno; Nanako Kumagai; Masakado Matsumoto; Yoshiro Morikawa; Tadayoshi Ikebe; Haruo Watanabe
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

5.  In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.

Authors:  K Lam; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

Review 6.  New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view.

Authors:  Jose M Lopez-Novoa; Yaremi Quiros; Laura Vicente; Ana I Morales; Francisco J Lopez-Hernandez
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

Review 7.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

8.  Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory.

Authors:  A Bizzini; C Durussel; J Bille; G Greub; G Prod'hom
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

Review 9.  Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features.

Authors:  Takashi Takahashi; Kimiko Ubukata; Haruo Watanabe
Journal:  J Infect Chemother       Date:  2010-07-06       Impact factor: 2.211

10.  Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes.

Authors:  Abdelghani El Rafei; Daniel C DeSimone; Christopher V DeSimone; Brian D Lahr; James M Steckelberg; Muhammad R Sohail; Walter R Wilson; Larry M Baddour
Journal:  Infect Dis (Lond)       Date:  2016-01-14
View more
  6 in total

1.  Virulence of beta-hemolytic streptococci in infective endocarditis.

Authors:  Yvon Ruch; Yves Hansmann; Philippe Riegel; Nicolas Lefebvre; Jean-Philippe Mazzucotelli; Nawal Douiri; Aurélie Martin; Xavier Argemi
Journal:  Infection       Date:  2019-09-13       Impact factor: 3.553

2.  Infective Endocarditis Due to Corynebacterium Species: Clinical Features and Antibiotic Resistance.

Authors:  Anna Bläckberg; Linn Falk; Karl Oldberg; Lars Olaison; Magnus Rasmussen
Journal:  Open Forum Infect Dis       Date:  2021-02-04       Impact factor: 3.835

3.  Surgery Is Underused in Elderly Patients With Left-Sided Infective Endocarditis: A Nationwide Registry Study.

Authors:  Sigurdur Ragnarsson; Sonsoles Salto-Alejandre; Axel Ström; Lars Olaison; Magnus Rasmussen
Journal:  J Am Heart Assoc       Date:  2021-09-24       Impact factor: 5.501

4.  Outcomes of surgical treatment for active infective endocarditis under COVID-19 pandemic.

Authors:  XinPei Liu; Qi Miao; XingRong Liu; ChaoJi Zhang; GuoTao Ma; JianZhou Liu
Journal:  J Card Surg       Date:  2022-02-25       Impact factor: 1.620

5.  Beta-Hemolytic Streptococcal Infective Endocarditis: Characteristics and Outcomes From a Large, Multinational Cohort.

Authors:  Núria Fernández Hidalgo; Amal A Gharamti; María Luisa Aznar; Benito Almirante; Mohamad Yasmin; Claudio Querido Fortes; Patrick Plesiat; Thanh Doco-Lecompte; Hussein Rizk; Dannah Wray; Cristiane Lamas; Emanuele Durante-Mangoni; Pierre Tattevin; Ulrika Snygg-Martin; Margaret M Hannan; Vivian H Chu; Zeina A Kanafani
Journal:  Open Forum Infect Dis       Date:  2020-04-10       Impact factor: 3.835

6.  Incidence of infective endocarditis caused by viridans group streptococci in Sweden - effect of cessation of antibiotic prophylaxis in dentistry for risk individuals.

Authors:  Niko Vähäsarja; Bodil Lund; Anders Ternhag; Bengt Götrick; Lars Olaison; Margareta Hultin; Carina Krüger Weiner; Aron Naimi-Akbar
Journal:  J Oral Microbiol       Date:  2020-05-23       Impact factor: 5.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.